UNSPSC 51381803: Talmetacin

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C27H20ClNO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6FY017I6S7, chemically known as 1,3-dihydro-3-oxo-1-isobenzofuranyl 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1h-indole-3-acetate but generally known as talmetacin, which bears US NIH Compound Identifier 68564. European Medicines Agency schedules Talmetacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10808MIG.

UNSPSC 51381803 Talmetacin, a Commodity code, represents pharmaceutical products and medical supplies acquired by state and local health agencies, though the single recent solicitation on record shows a notable mismatch between the code's nominal scope and actual procurement activity. Seminole County, Florida posted an IFB in June 2026 for naloxone and safe drug deactivation systems—opioid-overdose reversal agents and drug disposal equipment—rather than talmetacin, an anti-inflammatory medication. The solicitation required vendors to deliver 1,900 units of naloxone and 800 deactivation systems annually in quarterly shipments to the county's Community Health Building, with all shipping costs included in bids, drug-free workplace certification, E-Verify compliance, and standard commercial insurance (workers' compensation, general and professional liability). The contract offered an initial two-year term with a one-year renewal option and included a three-month probationary termination right; potential FEMA funding triggered additional federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

Geographic and issuing-body activity is limited to the single Seminole County opportunity with a response deadline of July 26, 2023 (predating the current date). The county's community health system is the primary—and only named—recent buyer under this code. Without additional recent solicitations from other state departments, counties, school districts, or health authorities across multiple jurisdictions, the code shows sparse recent activity and the talmetacin classification does not align with the naloxone and drug deactivation procurement posted. State and local buyers interested in this commodity should monitor for future opportunities from county health departments and state substance-abuse or emergency-management agencies, though current signals do not indicate active ongoing demand under this specific code.